These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 21126254
21. Hemoglobin-based oxygen carriers: a long road from bench to bedside. Quirolo K. Pediatr Hematol Oncol; 2007 Sep; 24(6):461-3. PubMed ID: 17710665 [No Abstract] [Full Text] [Related]
22. Red cell substitutes: a current appraisal. Gould SA, Sehgal LR, Sehgal HL, Moss GS. Schweiz Med Wochenschr Suppl; 1991 Sep; 43():65-9. PubMed ID: 1843040 [No Abstract] [Full Text] [Related]
24. Blood substitutes: oxygen-carrying acellular fluids. Wohl JS, Cotter SM. Vet Clin North Am Small Anim Pract; 1995 Nov; 25(6):1417-40. PubMed ID: 8619274 [Abstract] [Full Text] [Related]
25. Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents. Bucci E. Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):206-13. PubMed ID: 21692690 [Abstract] [Full Text] [Related]
26. Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Shoemaker SA, Gerber MJ, Evans GL, Archer-Paik LE, Scoggin CH. Artif Cells Blood Substit Immobil Biotechnol; 1994 Aug; 22(3):457-65. PubMed ID: 7994368 [No Abstract] [Full Text] [Related]
27. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example. Chang TM. Artif Cells Blood Substit Immobil Biotechnol; 2006 Aug; 34(6):551-66. PubMed ID: 17090428 [Abstract] [Full Text] [Related]
29. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
30. New and future resuscitation fluids for trauma patients using hemoglobin and hypertonic saline. Galvagno SM, Mackenzie CF. Anesthesiol Clin; 2013 Mar; 31(1):1-19. PubMed ID: 23351531 [Abstract] [Full Text] [Related]
31. Nanobiotechnology for hemoglobin-based blood substitutes. Chang TM. Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914 [Abstract] [Full Text] [Related]
32. Cross-linked hemoglobins being well into clinical trials, increasing research efforts are now on a second generation red blood cell substitute based on encapsulated hemoglobin. Chang TM. Artif Cells Blood Substit Immobil Biotechnol; 1995 Apr; 23(3):257-62. PubMed ID: 7493046 [No Abstract] [Full Text] [Related]
34. Haemoglobin-based oxygen carriers: indications and future applications. Njoku M, St Peter D, Mackenzie CF. Br J Hosp Med (Lond); 2015 Feb; 76(2):78-83. PubMed ID: 25671471 [Abstract] [Full Text] [Related]
35. Clinical application of a hemoglobin-based oxygen-carrying solution. Callan MB, Rentko VT. Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1277-93, vi. PubMed ID: 14664199 [Abstract] [Full Text] [Related]
37. Evaluation of the effects of bovine hemoglobin glutamer-200 on systolic arterial blood pressure in hypotensive cats: 44 cases (1997-2008). Wehausen CE, Kirby R, Rudloff E. J Am Vet Med Assoc; 2011 Apr 01; 238(7):909-14. PubMed ID: 21453180 [Abstract] [Full Text] [Related]
38. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Kim HW, Greenburg AG. Artif Organs; 2004 Sep 01; 28(9):813-28. PubMed ID: 15320945 [Abstract] [Full Text] [Related]
39. Human haemoglobin--Northfield. PolyHeme. Drugs R D; 2002 Sep 01; 3(2):121-2. PubMed ID: 12001815 [No Abstract] [Full Text] [Related]
40. The effect HBOC-201 and sodium nitrite resuscitation after uncontrolled haemorrhagic shock in swine. Moon-Massat P, Scultetus A, Arnaud F, Brown A, Haque A, Saha B, Kim B, Sagini E, McGwin G, Auker C, McCarron R, Freilich D. Injury; 2012 May 01; 43(5):638-47. PubMed ID: 21094491 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]